| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 22, 2004
Accepted on October 26, 2004
B repression
Dept. of Medical Nutrition (L-G.B., A.P., I.R., S.O.) and Biosciences (J.L., K.D-W.), Karolinska Institutet, Karolinska University Hospital Huddinge, Novum, SE-141 86 Huddinge, Sweden and KaroBio AB (L-G.B., S.N.), Novum, Huddinge, Sweden
* To whom correspondence should be addressed. E-mail: Sam.Okret{at}mednut.ki.se.
Glucocorticoid hormones (GCs) exert an anti-proliferative effect on most cells. However, the molecular mechanism is still largely unclear. We investigated the anti-proliferative mechanism by GCs in HEK293 cells with stably introduced glucocorticoid receptor (GR) mutants that discriminate between cross-talk with nuclear factor-kappaB (NF-
B) and activator protein-1 (AP-1) signaling, transactivation and transrepression, and anti-proliferative vs. non-anti-proliferative responses. Using the GR mutants, we here demonstrate a correlation between repression of NF-
B signaling and anti-proliferative response. Gene expression profiling of endogenous genes in cells containing mutant GRs identified a limited number of genes that correlated with the anti-proliferative response. This included a GC-mediated up-regulation of the NF-
B inhibitory protein I
B
, in line with repression of NF-
B signaling being important in the GC-mediated anti-proliferative response. Interestingly, the GC-stimulated expression of I
B
was a direct effect despite the inability of the GR mutant to transactivate through a GC-responsive element. Selective expression of I
B
in HEK293 cells resulted in a decreased percentage of cells in the S/G2/M phase and impaired cell proliferation. These results demonstrate that GC-mediated inhibition of NF-
B is an important mechanism in the anti-proliferative response to GCs.
B
AP-1
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
E. Donet, P. Bosch, A. Sanchis, P. Bayo, A. Ramirez, J. L. Cascallana, A. Bravo, and P. Perez Transrepression Function of the Glucocorticoid Receptor Regulates Eyelid Development and Keratinocyte Proliferation but Is Not Sufficient to Prevent Skin Chronic Inflammation Mol. Endocrinol., April 1, 2008; 22(4): 799 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Mao, A. K. Stewart, R. Hurren, A. Datti, X. Zhu, Y. Zhu, C. Shi, K. Lee, R. Tiedemann, Y. Eberhard, et al. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin Blood, December 1, 2007; 110(12): 4047 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Zhang and R. A. Daynes Glucocorticoid Conditioning of Myeloid Progenitors Enhances TLR4 Signaling via Negative Regulation of the Phosphatidylinositol 3-Kinase-Akt Pathway J. Immunol., February 15, 2007; 178(4): 2517 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Jordan Medroxyprogesterone Acetate and Metastases: Of Mice and (wo)Men J Natl Cancer Inst, May 4, 2005; 97(9): 619 - 621. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |